GlaxoSmithKline plc (ADR) (NYSE:GSK)

CAPS Rating: 4 out of 5

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products.

Recs

0
Player Avatar amckane (78.71) Submitted: 1/2/2011 10:54:23 PM : Outperform Start Price: $36.00 GSK Score: +17.86

It's a "dividend stock", the next "investing" fad!

Featured Broker Partners


Advertisement